nivolumab,ipilimumab
regeneron,bms
['nivolumab', 'nivo', 'ipilimumab', 'bristol', 'bms', 'regeneron']
 boss israel lowy in the house reviewing data #ipilimumab #nivolumab single agent and combo in multiple tumors. led the development of drugs at medarex and bristol. #muchrespect #awe why we do #clinicaltrials #asco23 
Chief of Research and Immunotherapy  •  ImmunoOncology  •  Phase I  Clinical Trials  •  Melanoma  •  Cutaneous Oncology